1. Home
  2. SHIM vs FHTX Comparison

SHIM vs FHTX Comparison

Compare SHIM & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shimmick Corporation

SHIM

Shimmick Corporation

SELL

Current Price

$3.10

Market Cap

160.8M

Sector

N/A

ML Signal

SELL

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

SELL

Current Price

$1.90

Market Cap

173.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
SHIM
FHTX
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.8M
173.4M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
SHIM
FHTX
Price
$3.10
$1.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
10
Target Price
$7.00
★ $9.89
AVG Volume (30 Days)
96.7K
★ 997.2K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 81.95
25.32
EPS
★ N/A
N/A
Revenue
★ $492,844,000.00
$30,909,000.00
Revenue This Year
$1.41
N/A
Revenue Next Year
$20.36
$15.98
P/E Ratio
★ N/A
N/A
Revenue Growth
2.63
★ 36.75
52 Week Low
$1.95
$1.79
52 Week High
$6.76
$7.61

Technical Indicators

Market Signals
Indicator
SHIM
FHTX
Relative Strength Index (RSI) 40.13 12.25
Support Level $2.45 N/A
Resistance Level $4.09 $5.35
Average True Range (ATR) 0.18 0.28
MACD -0.01 -0.16
Stochastic Oscillator 33.09 5.72

Price Performance

Historical Comparison
SHIM
FHTX

About SHIM Shimmick Corporation

Shimmick Corp is engaged in delivering turnkey infrastructure solutions that strengthen critical markets across water, energy, climate resiliency, and sustainable transportation. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains critical infrastructure, including mass transit, bridges, and military infrastructure. The company has one operating and reportable segment: infrastructure solutions. All of its revenue is derived from the United States.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: